Evidence map›Paper›PMID 37658807›Full record

ArticleAmerican journal of clinical pathology2023

A fully interpretable machine learning model for increasing the effectiveness of urine screening.

Fabio Del Ben, Giacomo Da Col, Doriana Cobârzan, Matteo Turetta, Daniela Rubin, Patrizio Buttazzi, Antonio Antico

Open access · hybridAbstract read
In one paragraph

Article in American journal of clinical pathology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Fabio Del BenCRO Aviano, National Cancer Institute, IRCCS, Aviano, Italy.ORCID 0000-0002-1880-0669
Giacomo Da ColKI4LIFE, Fraunhofer Austria Research, Klagenfurt, Austria.
Doriana CobârzanKI4LIFE, Fraunhofer Austria Research, Klagenfurt, Austria.
Matteo TurettaCRO Aviano, National Cancer Institute, IRCCS, Aviano, Italy.
Daniela RubinAULSS2 Marca Trevigiana, Treviso, Italy.
Patrizio ButtazziAULSS2 Marca Trevigiana, Treviso, Italy.
Antonio AnticoAULSS2 Marca Trevigiana, Treviso, Italy.
AULSS 2 Marca Trevigiana · ITCentro di Riferimento Oncologico · ITFraunhofer Austria · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis article addresses the need for effective screening methods to identify negative urine samples before urine culture, reducing the workload, cost, and release time of results in the microbiology laboratory. We try to overcome the limitations of current solutions, which are either too simple, limiting effectiveness (1 or 2 parameters), or too complex, limiting interpretation, trust, and real-world implementation ("black box" machine learning models).

methodsThe study analyzed 15,312 samples from 10,534 patients with clinical features and the Sysmex Uf-1000i automated analyzer data. Decision tree (DT) models with or without lookahead strategy were used, as they offer a transparent set of logical rules that can be easily understood by medical professionals and implemented into automated analyzers.

resultsThe best model achieved a sensitivity of 94.5% and classified negative samples based on age, bacteria, mucus, and 2 scattering parameters. The model reduced the workload by an additional 16% compared to the current procedure in the laboratory, with an estimated financial impact of €40,000/y considering 15,000 samples/y. Identified logical rules have a scientific rationale matched to existing knowledge in the literature.

conclusionsOverall, this study provides an effective and interpretable screening method for urine culture in microbiology laboratories, using data from the Sysmex UF-1000i automated analyzer. Unlike other machine learning models, our model is interpretable, generating trust and enabling real-world implementation.

Indexed as

Urinary Tract InfectionsBacteriaFlow CytometryHumansMachine LearningUrinalysisdata sciencedecision treemachine learningurinalysis

Identifiers

PMID37658807
PMCPMC10691191
OpenAlexW4386393097

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.